| Authors | Wenrong Huang, Jian Li, Honghua Li, Wenying Kang, Jian Bo, Yu Zhao, Chunji Gao, Daobin Zhou, Li Yu |
| Journal | Leukemia & lymphoma
(Leuk Lymphoma)
Vol. 53
Issue 12
Pg. 2507-10
(Dec 2012)
ISSN: 1029-2403 [Electronic] United States |
| PMID | 22512306
(Publication Type: Clinical Trial, Phase II, Letter)
|
| Chemical References |
- Boronic Acids
- Pyrazines
- Bortezomib
- Melphalan
|
| Topics |
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Bipolar Disorder
(etiology)
- Boronic Acids
(administration & dosage, adverse effects)
- Bortezomib
- Combined Modality Therapy
- Dose-Response Relationship, Drug
- Female
- Humans
- Induction Chemotherapy
(adverse effects, methods)
- Kaplan-Meier Estimate
- Male
- Melphalan
(administration & dosage, adverse effects)
- Middle Aged
- Multiple Myeloma
(diagnosis, therapy)
- Nausea
(etiology)
- Neutropenia
(etiology)
- Pyrazines
(administration & dosage, adverse effects)
- Remission Induction
- Stem Cell Transplantation
(adverse effects, methods)
- Transplantation Conditioning
(adverse effects, methods)
- Transplantation, Autologous
- Treatment Outcome
|
